Abstract:We report the development of a broadband rotary joint for high-speed ultrahigh-resolution endoscopic optical coherence tomography (OCT) imaging in the 800 nm spectral range. This rotary joint features a pair of achromatic doublets in order to achieve broadband operation for a 3 dB bandwidth over 150 nm. The measured one-way throughput of the rotary joint is greater than 80%, while the fluctuation of the double-pass coupling efficiency during 360 deg rotation is less than ±5% at a near video-rate speed of 20 re… Show more
“…A homemade broadband rotary joint was used to perform circumferential scan of the microneedle. The one-way throughput was greater than 80%, with a measured back reflection less than −60 dB and an optical coupling variation less than ±5% during continuous rotation (15).…”
Section: Methodsmentioning
confidence: 90%
“…Our microneedle adopted a monolithic fiber-optic design similar to the super-achromatic microprobe recently demonstrated for ultrahigh-resolution OCT imaging at 800 nm ( fig. S1A; see also Materials and Methods) (15). To incorporate a near-infrared (NIR) laser into the same needle for ablation, we modified the previous design by using a coating-striped single-mode fiber (HI780, Corning Inc.).…”
Section: Oct Microneedle With Laser Ablation Functionmentioning
confidence: 99%
“…By using a homemade broadband rotary joint, 3D volumetric imaging was performed by pulling back the rotating microneedle within the stationary sheath with a computerized linear translation stage at the proximal end of the probe (15). The pullback speed was used to control the separation (i.e., pullback pitch) between two adjacent circumferential images, and 10 m was used in our studies.…”
Section: Oct Microneedle With Laser Ablation Functionmentioning
confidence: 99%
“…The previously demonstrated super-achromatic monolithic fiber-optic ball lens design concept was adopted for the current 800-nm microneedle ( fig. S1A) (15). Specifically, it consists of a homemade fiberoptic ball lens of a 230-m-diameter and a 520-m-long coreless fiber spliced to a bare single-mode fiber.…”
Section: Microneedle Design and Fabricationmentioning
confidence: 99%
“…Optical coherence tomography (OCT) is an appealing technology for real-time 3D visualization of tissue microanatomy in vivo with an imaging depth of 1 to 3 mm (13)(14)(15). To go beyond the depth limitation, an OCT needle was proposed and demonstrated to enable interstitial imaging of solid tissues/organs (11,(16)(17)(18)(19)(20)(21).…”
Current minimally invasive optical techniques for in vivo deep-brain imaging provide a limited resolution, field of view, and speed. These limitations prohibit direct assessment of detailed histomorphology of various deep-seated brain diseases at their native state and therefore hinder the potential clinical utilities of those techniques. Here, we report an ultracompact (580 μm in outer diameter) theranostic deep-brain microneedle combining 800-nm optical coherence tomography imaging with laser ablation. Its performance was demonstrated by in vivo ultrahigh-resolution (1.7 μm axial and 5.7 μm transverse), high-speed (20 frames per second) volumetric imaging of mouse brain microstructures and optical attenuation coefficients. Its translational potential was further demonstrated by in vivo cancer visualization (with an imaging depth of 1.23 mm) and efficient tissue ablation (with a 1448-nm continuous-wave laser at a 350-mW power) in a deep mouse brain (with an ablation depth of about 600 μm).
“…A homemade broadband rotary joint was used to perform circumferential scan of the microneedle. The one-way throughput was greater than 80%, with a measured back reflection less than −60 dB and an optical coupling variation less than ±5% during continuous rotation (15).…”
Section: Methodsmentioning
confidence: 90%
“…Our microneedle adopted a monolithic fiber-optic design similar to the super-achromatic microprobe recently demonstrated for ultrahigh-resolution OCT imaging at 800 nm ( fig. S1A; see also Materials and Methods) (15). To incorporate a near-infrared (NIR) laser into the same needle for ablation, we modified the previous design by using a coating-striped single-mode fiber (HI780, Corning Inc.).…”
Section: Oct Microneedle With Laser Ablation Functionmentioning
confidence: 99%
“…By using a homemade broadband rotary joint, 3D volumetric imaging was performed by pulling back the rotating microneedle within the stationary sheath with a computerized linear translation stage at the proximal end of the probe (15). The pullback speed was used to control the separation (i.e., pullback pitch) between two adjacent circumferential images, and 10 m was used in our studies.…”
Section: Oct Microneedle With Laser Ablation Functionmentioning
confidence: 99%
“…The previously demonstrated super-achromatic monolithic fiber-optic ball lens design concept was adopted for the current 800-nm microneedle ( fig. S1A) (15). Specifically, it consists of a homemade fiberoptic ball lens of a 230-m-diameter and a 520-m-long coreless fiber spliced to a bare single-mode fiber.…”
Section: Microneedle Design and Fabricationmentioning
confidence: 99%
“…Optical coherence tomography (OCT) is an appealing technology for real-time 3D visualization of tissue microanatomy in vivo with an imaging depth of 1 to 3 mm (13)(14)(15). To go beyond the depth limitation, an OCT needle was proposed and demonstrated to enable interstitial imaging of solid tissues/organs (11,(16)(17)(18)(19)(20)(21).…”
Current minimally invasive optical techniques for in vivo deep-brain imaging provide a limited resolution, field of view, and speed. These limitations prohibit direct assessment of detailed histomorphology of various deep-seated brain diseases at their native state and therefore hinder the potential clinical utilities of those techniques. Here, we report an ultracompact (580 μm in outer diameter) theranostic deep-brain microneedle combining 800-nm optical coherence tomography imaging with laser ablation. Its performance was demonstrated by in vivo ultrahigh-resolution (1.7 μm axial and 5.7 μm transverse), high-speed (20 frames per second) volumetric imaging of mouse brain microstructures and optical attenuation coefficients. Its translational potential was further demonstrated by in vivo cancer visualization (with an imaging depth of 1.23 mm) and efficient tissue ablation (with a 1448-nm continuous-wave laser at a 350-mW power) in a deep mouse brain (with an ablation depth of about 600 μm).
PurposeThe purpose of this study was to evaluate the possible clinical application of optical coherence tomography for assessing ovarian reserve in individual specimens of human ovarian tissue for fertility preservation.MethodsOvarian tissue examination by optical coherence tomography was performed before ovarian tissue cryopreservation. Three of the four subjects had hematological disease or cancer, and they faced a threat to their fertility due to impending chemotherapy. One patient underwent ovarian tissue extraction for in vitro activation of dormant follicles as fertility treatment.ResultsThe current full-field optical coherence tomography technique can detect primordial follicles in non-fixed and non-embedded human ovarian tissue. These images are well correlated with histological evaluation and the ovarian reserve test, including follicle counts.ConclusionIt was demonstrated that optical coherence tomography could assess localization of primordial follicles and ovarian reserve in specimens of non-fixed human ovarian cortex, although optimization for examination of human ovarian tissue is needed for clinical application. Additionally, this technique holds the possibility of assessing the ovarian reserve of patients with unevaluable ovarian reserve.Trial registration number
UMIN000023141
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.